Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-10-003403)

Filing Details

Accession Number:: 0001179110-10-003403
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-02-22 12:00:00
Reporting Period:: 2010-02-19

Filing Date:: 2010-02-22
Accepted Time:: 2010-02-22 19:40:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1800	Abbott Laboratories	ABT	Pharmaceutical Preparations (2834)	360698440

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1239142	David Owen	78 Narrow Street Limehouse London E14 8BP		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares Without Par Value	Acquisiton	2010-02-19	5,010	$35.92	17,098	No	4	M	Direct
Common Shares Without Par Value	Disposition	2010-02-19	2,800	$54.28	14,298	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-19	1,800	$54.28	12,498	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-19	110	$54.28	12,388	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-19	100	$54.28	12,288	No	4	S	Direct
Common Shares Without Par Value	Disposition	2010-02-19	200	$54.28	12,088	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Option (right to buy)	Disposition	2010-02-19	5,010	$0.00	5,010	$35.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2000-04-28	2010-04-27	No	4	M	Direct

Footnotes

Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.